152
Views
10
CrossRef citations to date
0
Altmetric
Original Research

In vitro human skin permeation of endoxifen: potential for local transdermal therapy for primary prevention and carcinoma in situ of the breast

, , , &
Pages 61-70 | Published online: 14 Jul 2011

References

  • JordanVCChemoprevention of breast cancer with selective oestrogen-receptor modulatorsNat Rev Cancer200771465317186017
  • CuzickJPowlesTVeronesiUOverview of the main outcomes in breast-cancer prevention trialsLancet2003361935429630012559863
  • GoetzMPRaeJMSumanVJPharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashesJ Clin Oncol200523369312931816361630
  • GoetzMPKnoxSKSumanVJThe impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifenBreast Cancer Res Treat2007101111312117115111
  • WuXHawseJRSubramaniamMGoetzMPIngleJNSpelsbergTCThe tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cellsCancer Res20096951722172719244106
  • FisherBCostantinoJPWickerhamDLTamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJ Natl Cancer Inst19989018137113889747868
  • Mauvais-JavisPBaudotNCastaigneDBanzetPKuttennFtrans-4-Hydroxytamoxifen concentration and metabolism after local percutaneous administration to human breastCancer Res1986463152115253943109
  • PujolHGiraultJRouanetPPhase I study of percutaneous 4-hydroxy-tamoxifen with analyses of 4-hydroxy-tamoxifen concentrations in breast cancer and normal breast tissueCancer Chemother Pharmacol19953664934987554041
  • RouanetPLinares-CruzGDravetFNeoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifenJ Clin Oncol200523132980298715860853
  • BronaughRLStewartRFMethods for in vitro percutaneous absorption studies. VI: preparation of the barrier layerJ Pharm Sci19867554874913735088
  • ManselRGoyalANestourELMasini-EteveVO’ConnellKA phase II trial of Afimoxifene (4-hydroxytamoxifen gel) for cyclical mastalgia in premenopausal womenBreast Cancer Res Treat2007106338939717351746
  • LimYCDestaZFlockhartDASkaarTCEndoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifenCancer Chemother Pharmacol200555547147815685451
  • LimYCLiLDestaZEndoxifen, a secondary metabolite of tamoxifen, and 4-OH-tamoxifen induce similar changes in global gene expression patterns in MCF-7 breast cancer cellsJ Pharmacol Exp Ther2006318250351216690721
  • WilliamsACBarryBWPenetration enhancersAdv Drug Deliv Rev200456560361815019749
  • KimDDKimJLChienYWMutual hairless rat skin permeation-enhancing effect of ethanol/water system and oleic acidJ Pharm Sci19968511119111958923324
  • KimMJDohHJChoiMKSkin permeation enhancement of diclofenac by fatty acidsDrug Deliv200815637337918686081
  • GoodmanMBarryBWAction of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose techniqueJ Invest Dermatol19889143233273171212
  • FangJYHwangTLLeuYLEffect of enhancers and retarders on percutaneous absorption of flurbiprofen from hydrogelsInt J Pharm2003250231332512527159
  • YuBDongCYSoPTBlankschteinDLangerRIn vitro visualization and quantification of oleic acid induced changes in transdermal transport using two-photon fluorescence microscopyJ Invest Dermatol20011171162511442745
  • OgisoTPakuTIwakiMTaninoTPercutaneous penetration of fluorescein isothiocyanate-dextrans and the mechanism for enhancement effect of enhancers on the intercellular penetrationBiol Pharm Bull19951811156615718593481
  • CosmanFBaz-HechtMCushmanMShort-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literatureThromb Res2005116111315850603
  • CuzickJForbesJEdwardsRFirst results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trialLancet2002360933681782412243915
  • KhanSARogersMAKhuranaKKMeguidMMNumannPJEstrogen receptor expression in benign breast epithelium and breast cancer risk [see comments]J Natl Cancer Inst199890137429428781
  • RickettsDTurnbullLRyallGEstrogen and progesterone receptors in the normal female breastCancer Res199151181718222004366
  • AckermanABKesslerGGyorfTTsouHCGottliebGJContrary view: the breast is not an organ per se, but a distinctive region of skin and subcutaneous tissueAm J Dermatopathol200729221121817414452
  • PovoskiSPOlsenJOYoungDCProspective randomized trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancerAnn Surg Oncol2006132101116372150
  • KlimbergVSRubioITHenryRCowanCColvertMKorourianSSubareolar versus peritumoral injection for location of the sentinel lymph nodeAnn Surg1999229686086410363900
  • LienEASolheimEUelandPMDistribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatmentCancer Res19915118483748441893376